EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. The company is headquartered in Vaulx-En-Velin, Auvergne-Rhone-Alpes and currently employs 289 full-time employees. The firm's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. The company specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. The company also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
最新の財務諸表(Form-10K)によると、StoneBridge Acquisition II Corpの総資産は$0で、純損失は$0です。
EDAPの主要な財務比率は何ですか?
StoneBridge Acquisition II Corpの流動比率は0、純利益率は0、1株当たり売上高は$0です。
Edap TMS SAの収益はセグメントまたは地域別にどのように分けられていますか?
StoneBridge Acquisition II Corp の最大収益セグメントは Industrial and Defense で、最新の利益発表における収益は 419,785,000 です。地域別に見ると、United States が StoneBridge Acquisition II Corp の主要市場であり、収益は 422,857,000 です。
Edap TMS SAは収益を上げていますか?
いいえ、最新の財務諸表によると、StoneBridge Acquisition II Corpの純損失は$0です。